Development and In Vitro Characterization of Hyaluronic Acid-Based Coatings for Implant-Associated Local Drug Delivery Systems
Figure 7
(a) Representative photograph of an EDC/NHS-crosslinked HA coating on GPTMS-modified PA12 balloon catheter, (b) paclitaxel loss after one minute elution in DPBS/Tween-20, paclitaxel transfer upon expansion in silicone tube (30 s, 7 bar) and total drug load of EDC/NHS- and GDA-crosslinked HA coatings on GPTMS-modified PA12 balloon catheter () at °C, all data shown as mean ± SD, and (c) in vitro paclitaxel release from EDC/NHS- and GDA-crosslinked HA coatings on GPTMS-modified PA12 tubes () in DPBS/Tween 20 at °C.
